Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: A comprehensive population study

European Urology

Volumn 64, Issue 3, 2013, Pages 493-501

  Lukacs, Bertrand ^a   Cornu, Jean Nicolas ^a,b   Aout, Mounir ^c   Tessier, Natacha ^c   Hodée, Christophe ^d   Haab, François ^a   Cussenot, Olivier ^a   Merlière, Yvon ^e,f   Moysan, Véronique ^f   Vicaut, Eric ^c  

^a HÔPITAL TENON   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HÔPITAL FERNAND WIDAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e CREDOC (Centre de Recherche Pour l'Etude et l'Observation des Conditions de Vie)   (France)

^f Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

Author keywords

1 Blockers; 5 Reductase inhibitors; Benign prostatic obstruction; Claim database; Epidemiology; Phytotherapy; Population study

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; ENDOSCOPIC SURGERY; FOLLOW UP; FRANCE; HUMAN; HYPERTHERMIC THERAPY; INCIDENCE; LENGTH OF STAY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PHYTOTHERAPY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; REOPERATION; STRESS INCONTINENCE; SURVIVAL; TRANSURETHRAL INCISION OF THE PROSTATE; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; TREATMENT FAILURE; URETHRA STENOSIS; UROLOGIST;

5Α-REDUCTASE INHIBITORS; BENIGN PROSTATIC OBSTRUCTION; CLAIM DATABASE; EPIDEMIOLOGY; PHYTOTHERAPY; POPULATION STUDY; Α(1)-BLOCKERS;

5-ALPHA REDUCTASE INHIBITORS; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; AGED, 80 AND OVER; DATA MINING; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FRANCE; GENERAL PRACTICE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYTOTHERAPY; PLANT PREPARATIONS; PROSTATIC HYPERPLASIA; TIME FACTORS; TREATMENT OUTCOME; UROLOGIC SURGICAL PROCEDURES, MALE; UROLOGICAL AGENTS; UROLOGY;

EID: 84881140751     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.02.026     Document Type: Article

References (35)

1. J.T. Wei, E. Calhoun, and S.J. Jacobsen Urologic diseases in America project: Benign prostatic hyperplasia J Urol 179 Suppl 2008 S75 S80
2. A.V. Sarma, and J.T. Wei Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms N Engl J Med 367 2012 248 257
3. Oelke M, Bachmann A, Descazeaud A, et al. Guidelines on the treatment of non-neurogenic male LUTS. US Department of Health and Human Services Web site. http://guideline.gov/content.aspx?id=34066&search=luts#Section99999. Accessed July 24, 2012.
4. K.T. McVary, C.G. Roehrborn, and A.L. Avins Update on AUA guideline on the management of benign prostatic hyperplasia J Urol 185 2011 1793 1803
5. R. Rosen, J. Altwein, and P. Boyle Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7) Eur Urol 44 2003 637 649
6. S.A. Kaplan, C.G. Roehrborn, and C.R. Chapple Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms BJU Int 103 Suppl 3 2009 48 57
7. J. Logie, G.M. Clifford, and R.D. Farmer Incidence, prevalence and management of lower urinary tract symptoms in men in the UK BJU Int 95 2005 557 562
8. K.M. Verhamme, J.P. Dieleman, and G.S. Bleumink Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - the Triumph project Eur Urol 42 2002 323 328
9. M.S. Litwin, and C.S. Saigal Benign prostatic hyperplasia/lower urinary tract symptoms and bladder stones 2012 US Government Printing Office Washington, DC p. 46-72
10. C.G. Roehrborn, J.G. Nuckolls, J.T. Wei, W. Steers BPH Registry and Patient Survey Steering Committee The benign prostatic hyperplasia registry and patient survey: Study design, methods and patient baseline characteristics BJU Int 100 2007 813 819
11. M. Emberton Medical treatment of benign prostatic hyperplasia: Physician and patient preferences and satisfaction Int J Clin Pract 64 2010 1425 1435
12. K.M. Verhamme, J.P. Dieleman, G.S. Bleumink, J.L. Bosch, B.H. Stricker, and M.C. Sturkenboom Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: The Triumph project Eur Urol 44 2003 539 545
13. J.N. Cornu, O. Cussenot, F. Haab, and B. Lukacs A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines Eur Urol 58 2010 450 456
14. J.Y. Kang, G.E. Min, H. Son, H.T. Kim, and H.L. Lee National-wide data on the treatment of BPH in Korea Prostate Cancer Prostatic Dis 14 2011 243 247
15. L. Black, M.J. Naslund, T.D. Gilbert Jr., E.A. Davis, and D.A. Ollendorf An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia Am J Manag Care 12 Suppl 2006 S99 S110
16. C.R. Chapple BHP disease management. Introduction and concluding remarks Eur Urol 36 Suppl 3 1999 1 6
17. N. Black Experimental and observational methods of evaluation BMJ 309 1994 540
18. S. Madersbacher, G. Alivizatos, J. Nordling, C.R. Sanz, M. Emberton, and J.J. de la Rosette EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines) Eur Urol 46 2004 547 554
19. S.A. Kaplan AUA guidelines and their impact on the management of BPH: An update Rev Urol 6 Suppl 9 2004 S46 S52
20. S.A. Kaplan Update on the American Urological Association guidelines for the treatment of benign prostatic hyperplasia Rev Urol 8 Suppl 4 2006 S10 S17
21. Estimation de la population au 1er janvier par région (1990-2011), département (1990-2010), sexe et âge (quinquennal, classes d'âge). Institut National de la Statistique et des Etudes Economiques (INSEE) Web site. http://www.insee.fr/fr/themes/detail.asp?ref-id=estim- pop®-id=99. Accessed August 8, 2012.
22. M.J. Barry, S. Meleth, and J.Y. Lee Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: A randomized trial JAMA 306 2011 1344 1351
23. J. Tacklind, R. MacDonald, I. Rutks, and T.J. Wilt Serenoa repens for benign prostatic hyperplasia Cochrane Database Syst Rev 2009 CD001423
24. S. Bent, C. Kane, and K. Shinohara Saw palmetto for benign prostatic hyperplasia N Engl J Med 354 2006 557 566
25. J.D. McConnell, C.G. Roehrborn, and O.M. Bautista The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387 2398
26. J.M. Hollingsworth, B.K. Hollenbeck, S. Daignault, S.P. Kim, and J.T. Wei Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists J Urol 182 2009 2410 2414
27. S.R. Tunis, D.B. Stryer, and C.M. Clancy Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy JAMA 290 2003 1624 1632
28. B. Djulbegovic, and A. Paul From efficacy to effectiveness in the face of uncertainty: Indication creep and prevention creep JAMA 305 2011 2005 2006
29. L.O. Gostin Marketing pharmaceuticals: A constitutional right to sell prescriber-identified data? JAMA 307 2012 787 788
30. S.A. Strope, S.P. Elliott, and C.S. Saigal Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population Urology 78 2011 3 9
31. D.A. Zipkin, L. Greenblatt, and J.T. Kushinka Evidence-based medicine and primary care: Keeping up is hard to do Mt Sinai J Med 79 2012 545 554
32. T. Lourenco, R. Pickard, and L. Vale Alternative approaches to endoscopic ablation for benign enlargement of the prostate: Systematic review of randomised controlled trials BMJ 337 2008 a449
33. B.S. Malaeb, X. Yu, A.M. McBean, and S.P. Elliott National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008) Urology 79 2012 1111 1116
34. C.R. Chapple, and C.G. Roehrborn A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: Focus on the bladder Eur Urol 49 2006 651 659
35. M.S. Sarrazin, and G.E. Rosenthal Finding pure and simple truths with administrative data JAMA 307 2012 1433 1435